Hwail Pharma Upgraded to Blue-chip Section (May 4, 2026)
-
Hwail Pharmaceutical reclassified from Mid-sized Company Section to Blue-chip Section (effective May 4, 2026)
-
Reason: Meets blue-chip regular requirements (strong financial health and market evaluation)
-
This change signals improved corporate credibility and investor confidence
KOSDAQ Filing Information
-
Filing: Change of Listing Section
-
Company: Hwail Pharm (061250)
-
Submission: KOSDAQ Market Division
-
Receipt: 04-30-2026
-
Under KRX KOSDAQ Market Division